A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.

Trial Profile

A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2015

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms ACTS-RC
  • Most Recent Events

    • 22 Jun 2015 Planned End Date changed from 1 Mar 2014 to 1 Apr 2014 as reported by the University Hospital Medical Information Network - Japan record.
    • 29 May 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 29 May 2015 Primary endpoint has been met (relapse-free survival) according to results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top